Calmodulin-dependent protein phosphatase has been proposed to be an important phosphotyrosyl-protein phosphatase. The ability of the enzyme to attack autophosphorylated insulin receptor was examined and compared with the known ability of the enzyme to act on autophosphorylated epidermal-growth-factor (EGF) receptor. Purified calmodulin-dependent protein phosphatase was shown to catalyse the complete dephosphorylation of phosphotyrosyl-(insulin receptor). When compared at similar concentrations, 32p_ labelled EGF receptor was dephosphorylated at >3 times the rate of 32P-labelled insulin receptor; both dephosphorylations exhibited similar dependence on metal ions and calmodulin. Native phosphotyrosylprotein phosphatases in cell extracts were also characterized. With rat liver, heart or brain, most (75 %) of the native phosphatase activity against both 32P-labelled insulin and EGF receptors was recovered in the particulate fraction of the cell, with only 25 % in the soluble fraction. This subcellular distribution contrasts with results of previous studies using artificial substrates, which found most of the phosphotyrosyl-protein phosphatase activity in the soluble fraction of the cell. Properties of particulate and soluble phosphatase activity against 32P-labelled insulin and EGF receptors are reported. The contribution of calmodulindependent protein phosphatase activity to phosphotyrosyl-protein phosphatase activity in cell fractions was determined by utilizing the unique metal-ion dependence of calmodulin-dependent protein phosphatase. Whereas Ni2+ (1 mM) markedly activated the calmodulin-dependent protein phosphatase, it was found to inhibit potently both particulate and soluble phosphotyrosyl-protein phosphatase activity. In fractions from rat liver, brain and heart, total phosphotyrosyl-protein phosphatase activity against both 32P-labelled receptors was inhibited by 99.5+6% (mean+s.E.M., 30 observations) by Ni2+. Results of Ni2+ inhibition studies were confirmed by other methods. It is concluded that in cell extracts phosphotyrosyl-protein phosphatases other than calmodulin-dependent protein phosphatase are the major phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatases.
INTRODUCTION
Insulin is believed to elicit many of its actions by stimulating a tyrosine protein kinase activity intrinsic to the f-subunit of the insulin receptor (Kasuga et al., 1982; Ullrich et al., 1985; Ebina et al., 1987; Morgan & Roth, 1987; Chou et al., 1987;  for review see Sale, 1988) . This leads to autophosphorylation of the fl-subunit on tyrosine and phosphorylation of other proteins (White et al., 1985; Haring et al., 1987) . Autophosphorylation increases the receptor tyrosine kinase activity towards exogenous substrates. This activated state of the receptor is maintained even after removal of bound insulin (Rosen et al., 1983; Yu & Czech, 1984) . Thus dephosphorylation, and not simply dissociation of bound insulin, is required to terminate tyrosine kinase activity. Consequently the phosphotyrosyl-protein phosphatase(s) which catalyses dephosphorylation of the insulin receptor and cellular substrates phosphorylated on tyrosine plays a crucial role in terminating the insulin signal. Such phosphatases could also be subject to regulation and could thus play a key functional role in the overall scheme of insulin action.
At present, none of the native phosphotyrosyl-protein phosphatases active against either the insulin receptor or other tyrosine kinase-containing receptors and oncogene products have been purified to homogeneity and characterized; nor indeed is it known how many species of phosphatase account for all the phosphotyrosyl dephosphorylations of these various substrates. There have been no reports in which the insulin receptor has been used as substrate to characterize phosphotyrosyl-protein phosphatase(s). Previous studies in other systems have resulted in partial purifications of certain phosphotyrosyl-protein phosphatases, mainly by using artificial substrates such as phosphotyrosyl-(bovine serum albumin) (Foulkes et al., 1981 (Foulkes et al., , 1983 Chernoff & Li, 1983; Shriner & Brautigan, 1984; Okada et al., 1986; Rotenberg & Brautigan, 1987) . These substrates are far from ideal; e.g. phosphotyrosine may not be present within protein sequences representative of those found in the native receptors or oncogene products. Thus phosphatases with the greatest activity and specificity toward the receptor substrate or oncogene product of interest may be missed. Consequently, in the present work we have employed native autophosphorylated insulin receptor as substrate. The system used also contains the EGF receptor and thus affords the opportunity for the simultaneous study of phosphotyrosylprotein phosphatases active against both autophosphorylated insulin and EGF receptors. The system has been used in the present paper in two ways: firstly, to study the role of a known phosphatase, calmodulindependent protein phosphatase, and secondly to compare the properties and subcellular distributions of native cellular phosphatases active against the two receptors.
Abbreviation used: EGF, epidermal growth factor.
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Calmodulin-dependent protein phosphatase, also called protein phosphatase 2B or calcineurin, has emerged as a candidate for being a cellular phosphotyrosylprotein phosphatase. The enzyme has been observed to dephosphorylate phosphotyrosyl-(EGF receptor) (Pallen et al., 1985) and under certain conditions phosphotyrosyl residues with equal efficacy to phosphoseryl residues in synthetic peptides containing either a phosphotyrosyl or phosphoseryl residue present in an identical peptide sequence (Chan et al., 1986) . Thus it is important to test whether the phosphatase acts on other phosphotyrosyl proteins and to analyse its physiological role as a phosphotyrosyl-protein phosphatase. In the present work we have investigated whether autophosphorylated insulin receptor is a substrate for calmodulin-dependent protein phosphatase, and assessed the contribution of the phosphatase to total phosphotyrosyl-protein phosphatase activity in cell extracts against autophosphorylated insulin and EGF receptors.
EXPERIMENTAL Materials
Leupeptin, pepstatin A, antipain, z-casein and trifluoperazine were obtained from Sigma Chemical Co., Poole, Dorset, U.K. Calmodulin-dependent protein phosphatase purified from bovine brain and calmodulin were generously given by Dr. C. R. Klee (National Cancer Institute, Bethesda, MD, U.S.A.). Sephadex G-50 came from Pharmacia Fine Chemicals, Uppsala, Sweden. Soya-bean trypsin inhibitor was from BDH Chemicals, Poole, Dorset, U.K. Other chemicals and biochemicals were obtained from sources described in Smith et al. (1988) . Preparation of phosphorylated insulin and EGF receptors Insulin and EGF receptors were co-purified from solubilized human placental membranes by affinity chromatography on wheat-germ-agglutinin-agarose as previously described (Pike et al., 1984; Smith et al., 1988) . The receptors-were preincubated (approx. 1 mg of protein/ml) for 15 min at 22 'C in 0.15-0.45 ml of 50 mmHepes (pH 7.4)/0.1 % Triton X-100 in the presence of 2 mM-MnCl2, Io mM-MgCl2 and 100 nM-insulin (Sale et al., 1986) . Phosphorylation reactions were initiated by addition of [y-32P]ATP (100 /tM, 5-30 c.p.m./fmol) and were allowed to proceed at 22 'C for 10 min. Excess [y-32P]ATP and metal ions that would interfere with phosphatase assays were then removed by rapid gel filtration at 4 'C on a small Sephadex G-50 column (2.5-4.5 ml) equilibrated in 50 mM-Hepes (pH 7.4)/0.1 % Triton X-100. (1970) sample buffer (100 mM-Tris/HCl, pH 7.4, 10 % SDS, 75 mg of dithiothreitol/ml, 0.1 % Bromophenol Blue) and heating the samples at 100°C for 2 min. Sucrose was added to a final concentration of 200 mg/ml and samples were analysed by SDS/polyacrylamide-gel electrophoresis on 4 %-acrylamide stacking and 7.5%-acrylamide resolving gels (Laemmli, 1970) . Electrophoresis was performed at 20°C for approx. 3 h at 30-35 mA. Gels were stained for 20 min with 0.250% Coomassie Brilliant Blue in 50 % (w/v) trichloroacetic acid, destained overnight in 5 % acetic acid/45 % methanol (both v/v) and dried in vacuo for 1 h at 80 'C. Autoradiography, measurement of 32P associated with appropriate bands and phosphoamino acid analysis were performed as described previously (Smith et al., 1988) .
Assay of purified calmodulin-dependent protein phosphatase with p-nitrophenol phosphate as substrate was performed as described previously (Pallen & Wang, 1983; Pallen et al., 1985) . The phosphatase activated by Mn2+/Ca2+/calmodulin used in the present work had a specific activity against p-nitrophenol phosphate of 1174 nmol/min per mg in the presence of 0.09 % Triton X-100. This specific activity is comparable with previously reported values for the purified phosphatase with this substrate (Pallen & Wang, 1983; Pallen et al., 1985) . Preparation of particulate and soluble fractions All operations were performed at 4 'C. The liver (8-12 g) from one male Wistar rat (200-300 g) was homogenized for 2 x 15 s in a motor-driven Teflon/ glass homogenizer in 50 mM-Hepes (pH 7.0; 2 ml/g), containing 5 mM-EDTA, 0.5 mM-EGTA, I mm-dithiothreitol, a 1: 1000 dilution of 2.5 % (v/v) phenylmethanesulphonyl fluoride dissolved in propan-2-ol, and 1 jug each of leupeptin, antipain, pepstatin A and soya-bean trypsin inhibitor/ml. The homogenate was centrifuged at 500 g for 5 min. The particulate and soluble fractions were isolated by centrifuging the 500 g supernatant at 100000 g for 1 h. The supernatant obtained represents the soluble fraction. The particulate fraction was obtained by washing and resuspending the pellet in the above buffer. Both soluble and particulate fractions were usually adjusted to give a protein concentration of 5.5 mg/ml (biuret), and 5 4u1 was used in the dephosphorylation assays except where stated otherwise. In experiments examining the effect of EDTA on phosphatase activity EDTA and EGTA were omitted; this did not affect recovery of phosphatase activity. Preparation of particulate and soluble fractions from other rat tissues followed a similar protocol. (Pike et al., 1984; Smith et al., 1988) . Identity of the 32P-labelled bands was confirmed by showing insulin or EGF stimulation of phosphorylation of the Mr-95000 and Mr-170000 bands respectively, and by using specific antibodies (results not shown). The phosphorylation of the receptors was routinely performed in the presence of insulin but in the absence of EGF, because this gave an approximately equal labelling intensity of the two receptors. EGF is known only to alter the rate of phosphorylation of the same phosphorylation sites in the EGF receptor (Downward et al., 1984) . Excision of the Mr-170000 or Mr-95000 bands and phosphoamino acid analysis showed that > 95 % and approx. 80 % respectively, of 32P recovered in phosphoamino acids was attached to tyrosine (e.g. see Fig. 3 ). The preparation was essentially devoid of phosphotyrosylprotein phosphatase activity (0-1 % dephosphorylation/ min). Thus two suitable substrates for assaying phosphotyrosyl-protein phosphatase activity have been copurified. This system has been used in two ways to study phosphotyrosyl-protein phosphatases: firstly, to study a known phosphatase, calmodulin-dependent protein phosphatase, and secondly to study phosphatases in cell extracts. In both cases, 32P associated with the receptors was determined after separation of proteins by SDS/ polyacrylamide-gel electrophoresis. Provided that the extent of receptor dephosphorylation did not exceed 40 0 under the assay conditions used, the extent of dephosphorylation was acceptably proportional to the amount of phosphatase activity added (e.g. see Fig. 4b for exact relationship). As the extent of dephosphorylation increased above 40 %, disproportionality became increasingly evident. Thus in assays comparing the amount of phosphatase activity, the amount of phosphatase activity added was routinely restricted to that required to elicit < 400 dephosphorylation. Calmodulin-dependent protein phosphatase Calmodulin-dependent protein phosphatase was routinely activated by preincubation with Ca2l (1 mM)/ Mn2+ (1 mM)/calmodulin (1 /uM) and then incubated with 32P-labelled receptors under similar conditions. The activated phosphatase was shown for the first time to be capable of completely dephosphorylating phosphotyrosyl-(insulin receptor) ( Fig. 1 ). Phosphotyrosyl-(EGF receptor) was also shown to be dephosphorylated by calmodulin-dependent protein phosphatase, confirming observations by Pallen et al. (1985) . The dependence of calmodulin-dependent protein phosphatase activity against 32P-labelled receptors on metal ions and calmodulin was characterized ( , 1984; King & Huang, 1983; Li, 1984; Merat et al., 1984; Pallen et al., 1985; Chan et al., 1986) . These results therefore strongly suggest that the observed phosphotyrosyl-protein phosphatase activity was intrinsic to calmodulin-dependent protein phosphatase and not attributable to another enzyme contaminating the preparation. Zn2+ (500,CM) or vanadate (20 ,tM), two known phosphotyrosyl-protein phosphatase inhibitors (Brautigan et al., 1981; Swarup et al., 1982) , completely inhibited the dephosphorylation of both 32P-labelled insulin and EGF receptors catalysed by Mn2+/Ca2+/ calmodulin-activated phosphatase (Fig. 1 ). Fig. 2 shows the time course of dephosphorylation of 32P-labelled insulin and EGF receptors. When similar amounts of 32p were present in EGF and insulin receptors, the 32p_ labelled EGF receptor was dephosphorylated at > 3 times the rate of the 32P-labelled insulin receptor. Insulin receptor isolated by the protocol employed was phosphorylated on both tyrosine and serine residues in the presence of insulin ( Fig. 3 ; Smith et al., 1988) , whereas the EGF receptor was > 95 % phosphorylated tyrosyl-protein phosphatase activity against "P-labelled insulin and EGF receptors determined in subcellular fractions from brain (which has been reported to contain the highest concentration of calmodulin-dependent protein phosphatase activity; Wallace et al., 1980) and heart was inhibited by 90-100 % by 1 mM-Ni2+ (results not shown). Therefore, on the basis of studies with Ni2l, calmodulin-dependent protein phosphatase does not contribute significantly to phosphotyrosyl-protein phosphatase activity in extracts from rat liver, heart and brain. In a second approach towards determining the contribution of calmodulin-dependent protein phosphatase to phosphotyrosyl-protein phosphatase activity, use was made of the facts that calmodulin-dependent protein phosphatase is inactive in the presence of 1 mM-EDTA, and is highly active in the presence of 1 mM-Mn2/1 mmCa2!/ 1 /M-calmodulin (Table 1, Fig. 6 ). Therefore an estimate of the relative amount of phosphotyrosylprotein phosphatase due to calmodulin-dependent protein phosphatase can be obtained by comparing the activity in the presence of EDTA with that in the presence of Mn24/Ca24/calmodulin. Activity of phosphotyrosylprotein phosphatase in liver particulate and soluble fractions against 32P-labelled insulin or EGF receptors was high in the presence of EDTA and was not further increased by Mn24/Ca24/calmodulin (Fig. 6) . In fact, Mn24/Ca24/calmodulin caused a slight inhibition (25 %), owing to the inhibitory action of Mn24, and gave phosphatase activities identical with that measured with Mn24 alone. Because calmodulin-dependent protein phosphatase is only partially active with Mn24, and is stimulated a further 3-4-fold on addition of Ca24/ calmodulin, the lack of any difference between effects of Mn24 and Mn24/Ca24/calmodulin showed that the contribution of calmodulin-dependent protein phosphatase to phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatase activity was low. Similar results were obtained in extracts from heart and brain. Thus results with Mn24/Ca24/calmodulin support those obtained with Ni2+.
RESULTS

Phosphotyrosyl
Both results obtained with Ni2l and Mn2+/Ca2+/ calmodulin were validated by performining dephosphorylation assays over a wider range of 32P-labelled insulin and EGF receptor dephosphorylation than those shown in Fig. 6 (i.e. removal of 20-90% of the 32p; results not shown). Although calmodulin-dependent protein phosphatase is well known to be stable in the buffer used to prepare extracts (i.e. in the presence of EDTA/ EGTA/proteinase inhibitors; see, e.g., Klee et al., 1983) , there has been a report that the enzyme in skeletalmuscle extracts is unstable on incubation with Mn2+ or Ca2+ in the absence of proteinase inhibitors . In the present work proteinase inhibitors were present throughout preincubation and incubation of extracts. To exclude further the possibility that proteolysis of calmodulin-dependent phosphatase during preincubation or incubation of extracts was interfering with the results, two types of experiment were conducted. Firstly, careful analysis by the procedure was undertaken. This procedure is designed for assaying calmodulin-dependent protein phosphatase in cell extracts and minimizing proteolysis. Thus, shorter preincubation/incubation times than those used in Fig.  6 , including omitting preincubation altogether, were tried. Under all conditions Ni24 fully inhibited and Mn24/ Ca24/calmodulin failed to increase phosphotyrosylprotein phosphatase activities. Secondly, to provide a positive control, calmodulin-dependent protein phosphatase was assayed in extracts with [32P] phosphoseryla-casein as substrate (0.2 mg/ml, 1-2 min incubations; Tallant & Cheung, 1984; Chernoff et al., 1984) . Assay of calmodulin-dependent protein phosphatase in extracts is complicated by a high background of activity due to other phosphoseryl-protein phosphatases. This was overcome by selectively assaying calmodulin-dependent protein phosphatase, based on its inhibition by trifluoperazine . Extracts from brain, liver and heart were incubated with 1 mM-Ca24 and 1 /,Mcalmodulin, with or without 100 /tM-trifluoperazine. Trifluoperazine-sensitive activity was approx. 35 % (brain), 12 % (liver) and 10 % (heart) of total activity, and was > 80 % stable during incubation at 30°C for 20 min. The proportion of activity inhibited by trifluoperazine in brain extracts is similar to that reported by , although values for all three tissues are somewhat higher than those evident from the data of Ingebritsen et al. (1983) , presumably reflecting the use of a different substrate.
In previous studies, high activities of phosphotyrosylcasein, -albumin or -IgG phosphatase were noted in the presence of EDTA or EDTA/NaF. These studies did not, however, exclude a contribution of calmodulindependent protein phosphatase to the phosphotyrosylprotein phosphatase activity, because comparative measurements were not made under conditions whereby calmodulin-dependent protein phosphatase was highly active (Brautigan et al., 1981; Foulkes et al., 1983; Chernoff & Li, 1983; Shriner & Brautigan, 1984) . Although Foulkes et al. (1983) Li, 1983; Shriner & Brautigan, 1984; Okada et al., 1986) and found no more than 36-45 % of the phosphatase in membrane fractions (Martensen, 1982; Nelson & Branton, 1984; Rotenberg & Brautigan, 1987) . This difference may be attributable to the use of non-specific artificial substrates in the previous studies, whereas specific receptor substrates have been utilized in the present work. Determination of the precise subcellular location of the particulate enzyme is clearly important, and requires further study. Particulate and soluble phosphotyrosylprotein phosphatase activities against either receptor were inhibited by vanadate and were active in the presence of EDTA, distinguishing them from acid and alkaline phosphatase (Swarup et al., 1981; Leis & Kaplan, 1982; Li et al., 1984; Chernoff & Li, 1985) . Several species of phosphotyrosyl-protein phosphatase with activity against phosphotyrosyl-casein, -IgG, -albumin and -p1 30gagf-Ps have been partially purified (Foulkes et al., 1983; Chernoff & Li, 1983; Shriner & Brautigan, 1984; Okada et al., 1986; Rotenberg & Brautigan, 1987) . All have broadly similar properties to those found for the phosphatases active against autophosphorylated insulin and EGF receptors in the present work. Solubilization of the particulate fraction with 2 % Triton X-100 quantitatively extracted the phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatase activities (results not shown). 32P-labelled EGF receptor was shown to be the preferred substrate, rather than 32P-labelled insulin receptor, for cytosolic, particulate and calmodulindependent protein phosphatases. Selective dephosphorylation of tyrosine residues in the insulin receptor by phosphotyrosyl-protein phosphatase (e.g. as in Fig. 5 ) may facilitate elucidation of the function of insulin-stimulated serine phosphorylation ofthe receptor.
The physiological role of calmodulin-dependent protein phosphatase as a phosphotyrosyl-receptor phosphatase was assessed. The assay of both native and calmodulin-dependent phosphotyrosyl-protein phosphatases in a single study against the same substrates permits the contribution of calmodulin-dependent protein phosphatase activity to total phosphotyrosyl-protein phosphatase activity to be calculated as follows. Tissue contents of calmodulin-dependent protein phosphatase are approx. 25, 12 and 5 mg/kg in both particulate and soluble phases of rat brain, liver and heart respectively (Wallace et al., 1980; Ingebritsen et al., 1983) . Efficient dephosphorylation of receptors required 320 ,zg of calmodulin-dependent protein phosphatase/ml activated by the physiological activators Ca2+ and calmodulin. Concentrations of particulate and soluble extracts that achieved the same rates of dephosphorylation contain at most 0.4, 1.2 and 3.6,Cg of calmodulin-dependent protein phosphatase/ml for heart, liver and brain respectively. On this basis the contribution of calmodulin-dependent protein phosphatase to phosphotyrosyl-protein phosphatase activity is < 1.2%. Because and -(EGF receptor) phosphatases.
In conclusion, this work introduces Ni" as a new inhibitor of particulate and soluble phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatases and illustrates its usefulness in demonstrating that the contribution of calmodulin-dependent protein phosphatase to the phosphatase activities is small. The finding that the vast bulk (75 %) of native phosphotyrosyl-(insulin receptor) and -(EGF receptor) phosphatase activity is membrane-associated places the phosphatases in the correct proximity to attack membrane-bound receptors. Cytosolic phosphotyrosyl-protein phosphatases may act principally on soluble substrates of the membraneassociated tyrosine kinases, rather than the receptors themselves. Most phosphotyrosyl-protein phosphatases have so far been recovered from the cytosol (Foulkes et al., 1981 (Foulkes et al., , 1983 Chernoff & Li, 1983; Shriner & Brautigan, 1984) , although Rotenberg & Brautigan (1987) have succeeded in partially purifying a catalytic fragment released from membranes by proteinases that has activity against a phosphotyrosyl residue in reduced and alkylated bovine serum albumin. The intact forms of phosphotyrosyl-protein phosphatases of membranes have not been isolated. Future work on the receptor phosphatases should place greater emphasis on characterizing the membrane-associated phosphotyrosyl-protein phosphatases.
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